The Medical Research Council (MRC) has announced a £50 million investment in the new MRC Centre of Research Excellence in Mitochondrial Genome Therapeutics, which aims to enable new treatments into potentially fatal mitochondrial DNA diseases.
LifeArc Centre for Rare Mitochondrial Disease and MitoCAMB are incredibly excited to share that our very own WP3 Co-Lead Prof Michal Minczuk will head up the new MRC Centre of Research Excellence (CoRE) in Mitochondrial Genome Therapeutics.
Prof Michal Minczuk Centre lead said:
“The MRC CoRE will provide pioneering approaches to understanding and treating diseases caused by mutations in the mitochondrial genome. We will be building a long-term UK research platform with the scale, expertise and infrastructure needed to position the UK as a global leader in mitochondrial genome therapeutics. Our goal is to create the scientific foundations that will enable entirely new therapeutic strategies and offer renewed hope to patients and families affected by mitochondrial disease.”
This centre will bring together leading experts from across disciplines to define how mutations in mitochondrial DNA (mtDNA) cause disease.
Other LifeArc Centre for RMD colleagues will be part of the centre Senior Leadership team:
Prof Rita Horvath
“I am delighted to be part of this new Centre! It is a privilege to work alongside such dedicated colleagues, and I hope that our work will make a real difference to the lives of people and families affected by mitochondrial disease.”
Jelle van den Ameele:
“Caring for people with mitochondrial disease and studying these conditions, I see every day how urgently better treatments are needed. I’m really grateful for the opportunity to be part of this new MRC CoRE, which brings together an exceptional community of patients, clinicians and scientists from across the world.”
More information on the MRC Centre of Research Excellence (CoRE) in Mitochondrial Genome Therapeutics :
https://www.ukri.org/news/mrc-funds-world-class-research-into-fatal-genetic-diseases/
https://www.cam.ac.uk/research/news/cambridge-to-lead-new-ps50-million-centre-to-study-mitochondrial-dna-diseases